Autonomix Medical (NASDAQ:AMIX – Get Free Report) and INVO Bioscience (NASDAQ:INVO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.
Risk and Volatility
Autonomix Medical has a beta of -5.4, meaning that its stock price is 640% less volatile than the S&P 500. Comparatively, INVO Bioscience has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Autonomix Medical and INVO Bioscience, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Autonomix Medical | 0 | 0 | 1 | 0 | 3.00 |
| INVO Bioscience | 0 | 0 | 0 | 0 | 0.00 |
Valuation & Earnings
This table compares Autonomix Medical and INVO Bioscience”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Autonomix Medical | N/A | N/A | -$15.43 million | ($12.93) | -0.15 |
| INVO Bioscience | $5.77 million | 1.59 | -$8.03 million | N/A | N/A |
INVO Bioscience has higher revenue and earnings than Autonomix Medical.
Profitability
This table compares Autonomix Medical and INVO Bioscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Autonomix Medical | N/A | -212.48% | -161.13% |
| INVO Bioscience | -122.79% | N/A | -36.94% |
Institutional and Insider Ownership
10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 12.0% of INVO Bioscience shares are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by company insiders. Comparatively, 3.5% of INVO Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
INVO Bioscience beats Autonomix Medical on 6 of the 11 factors compared between the two stocks.
About Autonomix Medical
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
About INVO Bioscience
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
